← 產業報告目錄

North America, Europe, and Asia-Pacific Large Molecule Bioanalysis Testing Services Market Research Report Forecast to 2030

出版商 Market Research Future產業別 Chemicals & Materials出版日期 2024-01-15頁數 145報告編號 MRF-7a6bda46e0

授權報價

Single User Price$2,950 USD
Multi User Licence (up to 10 users)$3,950 USD
Enterprisewide Price (Global Site License)$5,250 USD
洽詢購買 申請 Sample

報告摘要

North America, Europe, and Asia-Pacific Large Molecule Bioanalysis Testing Services Market Research Report Forecast to 2030 Market Overview The market for large molecule bioanalysis testing services in North America, Europe, and Asia-Pacific is expanding due to rising demand for high-tech and dependable large molecule bioanalytical testing services, a growing trend of outsourcing laboratory testing services, and an increase in the number of clinical trials. However, the difficulties in developing appropriate analytical techniques are limiting the growth of the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market. Furthermore, the growing prevalence of chronic diseases is expected to provide lucrative growth opportunities for the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market. The concentration of large molecules in biological samples such as proteins and antibodies are determined using large molecule bioanalytical testing services. Large molecules are frequently utilized in drug development, and bioanalytical testing is required to ensure these drugs' safety and efficacy. The expected growth in market can be attributed to the increasing demand for high-tech and reliable large molecule bioanalytical testing services, growing trend of outsourcing laboratory testing services, and rising R&D expenditure in the biopharmaceutical sector. However, the market is also held back by challenges in the development of proper analytical techniques. Nevertheless, it is anticipated that the growing incidence of chronic diseases will create lucrative opportunities for the players operating in the North America, Europe, And Asia-Pacific large molecule bioanalysis testing services market. MARKET SEGMENTATION Based on test type, the large molecule bioanalysis testing market has been segmented into pharmacokinetic (PK) studies, pharmacodynamic studies, bioequivalence studies, immunogenicity testing, biomarker testing and others. Based on therapeutic area, the market has been segmented into oncology, infectious diseases, cardiovascular diseases, neurology, autoimmune disorders, and others. Based on test type, the market has been segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), academic and research institutes, and others. Regional Analysis Based on region, the large molecule bioanalysis testing services market has been segmented into North America, Europe, and Asia-Pacific. North America accounted for the largest market share of 45.29% in 2022 and is anticipated to reach approximately USD 1,498.85 million by 2030 at an 8.70% CAGR during the forecast period. However, Asia-Pacific is projected to register the highest CAGR of 11.52% by 2030. MAJOR PLAYERS America Holdings (US), ICON plc (Ireland), SGS Société Générale de Surveillance SA (Switzerland), WuXi AppTec (China), Charles River Laboratories (US), Eurofins Scientific (luxembourg), QPS Holdings (US), BioTechne (US), PPD, Inc (US), BioAgilytix Labs (US), Smithers (US), Meso Scale Diagnostic, LLC (US), and CMIC HOLDINGS CO., LTD (Japan).
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 17 1.1 OVERVIEW 17 2 MARKET INTRODUCTION 19 2.1 DEFINITION 19 2.2 SCOPE OF THE STUDY 19 2.3 RESEARCH OBJECTIVE 19 2.4 MARKET STRUCTURE 20 2.5 ASSUMPTIONS & LIMITATIONS 20 3 RESEARCH METHODOLOGY 21 3.1 DATA MINING 21 3.2 SECONDARY RESEARCH 22 3.3 PRIMARY RESEARCH 23 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24 3.5 FORECASTING TECHNIQUES 25 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26 3.6.1 BOTTOM-UP APPROACH 26 3.6.2 TOP-DOWN APPROACH 27 3.7 DATA TRIANGULATION 27 3.8 VALIDATION 28 4 MARKET DYNAMICS 29 4.1 OVERVIEW 29 4.2 DRIVERS 30 4.2.1 INCREASING DEMAND FOR HIGH-TECH AND RELIABLE LARGE MOLECULE BIOANALYTICAL TESTING SERVICES 30 4.2.2 GROWING TREND OF OUTSOURCING LABORATORY TESTING SERVICES 30 4.2.3 RISING R&D EXPENDITURE IN THE BIOPHARMACEUTICAL SECTOR 30 4.3 RESTRAINTS 31 4.3.1 CHALLENGES IN THE DEVELOPMENT OF PROPER ANALYTICAL TECHNIQUES 31 4.4 OPPORTUNITIES 32 4.4.1 GROWING INCIDENCE OF CHRONIC DISEASES 32 5 MARKET FACTOR ANALYSIS 33 5.1 VALUE CHAIN ANALYSIS 33 5.1.1 CUSTOMER ACQUISITION (PRE-PURCHASE QUERY) 33 5.1.2 SERVICE CUSTOMIZATION 34 5.1.3 CUSTOMER PURCHASE SUPPORT 34 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT 34 5.2 PORTER'S FIVE FORCES MODEL 35 5.2.1 THREAT OF NEW ENTRANTS 36 5.2.2 BARGAINING POWER OF SUPPLIERS 36 5.2.3 THREAT OF SUBSTITUTES 36 5.2.4 BARGAINING POWER OF BUYERS 36 5.2.5 INTENSITY OF RIVALRY 36 5.3 IMPACT OF COVID-19 ON THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 37 5.3.1 IMPACT ON SUPPLY CHAIN 37 5.3.2 IMPACT ON SERVICE PROVIDER 37 6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE 38 6.1 OVERVIEW 38 6.2 PHARMACOKINETIC (PK) STUDIES 40 6.3 PHARMACODYNAMIC (PD) STUDIES 41 6.4 BIOEQUIVALENCE STUDIES 41 6.5 BIOMARKER TESTING 42 6.6 IMMUNOGENICITY TESTING 42 6.7 OTHERS 43 7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA 44 7.1 OVERVIEW 44 7.2 ONCOLOGY 46 7.3 INFECTIOUS DISEASES 47 7.4 CARDIOVASCULAR DISEASE 47 7.5 NEUROLOGY 47 7.6 AUTOIMMUNE DISORDERS 48 7.7 OTHERS 48 8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER 49 8.1 OVERVIEW 49 8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 51 8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS) 52 8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 52 8.5 ACADEMIC AND RESEARCH INSTITUTES 53 8.6 OTHERS 53 9 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION 54 9.1 OVERVIEW 54 9.2 NORTH AMERICA 58 9.2.1 US 61 9.2.2 CANADA 63 9.3 EUROPE 65 9.3.1 GERMANY 69 9.3.2 FRANCE 71 9.3.3 UK 72 9.3.4 ITALY 74 9.3.5 SPAIN 75 9.3.6 SWITZERLAND 77 9.3.7 NETHERLANDS 78 9.3.8 BELGIUM 80 9.3.9 SWEDEN 81 9.3.10 NORWAY 83 9.3.11 DENMARK 84 9.3.12 IRELAND 86 9.3.13 FINLAND 87 9.3.14 REST OF EUROPE 89 9.4 ASIA-PACIFIC 91 9.4.1 CHINA 95 9.4.2 INDIA 96 9.4.3 JAPAN 98 9.4.4 SOUTH KOREA 99 9.4.5 AUSTRALIA 101 9.4.6 REST OF ASIA-PACIFIC 102 10 COMPETITIVE LANDSCAPE 104 10.1 OVERVIEW 104 10.2 COMPETITIVE BENCHMARKING 106 10.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CATEGORY 106 10.3.1 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY PHARMA 106 10.3.2 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CDMO 107 10.3.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CRO 107 10.3.4 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY ACADEMIC AND RESEARCH INSTITUTIONS 108 10.4 MAJOR GROWTH STRATEGY IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 108 10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 109 10.6 KEY DEVELOPMENT ANALYSIS 110 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 110 10.7.1 EXPANSION 110 10.8 MAJOR PLAYERS FINANCIAL 111 10.8.1 SALES (USD MILLION), 2022 111 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022 111 11 COMPANY PROFILES 112 11.1 LABORATORY CORPORATION OF AMERICA HOLDINGS 112 11.1.1 COMPANY OVERVIEW 112 11.1.2 FINANCIAL OVERVIEW 113 11.1.3 SERVICES OFFERED 113 11.1.4 KEY DEVELOPMENTS 114 11.1.5 SWOT ANALYSIS 114 11.1.6 KEY STRATEGIES 114 11.2 PPD INC 115 11.2.1 COMPANY OVERVIEW 115 11.2.2 FINANCIAL OVERVIEW 115 11.2.3 SERVICES OFFERED 115 11.2.4 KEY DEVELOPMENTS 115 11.2.5 SWOT ANALYSIS 116 11.2.6 KEY STRATEGIES 116 11.3 EUROFINS SCIENTIFIC 117 11.3.1 COMPANY OVERVIEWS 117 11.3.2 FINANCIAL OVERVIEW 118 11.3.3 SERVICES OFFERED 118 11.3.4 KEY DEVELOPMENTS 119 11.3.5 SWOT ANALYSIS 119 11.3.6 KEY STRATEGIES 119 11.4 WUXI APPTEC 120 11.4.1 COMPANY OVERVIEW 120 11.4.2 FINANCIAL OVERVIEW 121 11.4.3 SERVICES OFFERED 122 11.4.4 KEY DEVELOPMENTS 122 11.4.5 KEY STRATEGIES 122 11.5 QPS HOLDINGS 123 11.5.1 COMPANY OVERVIEW 123 11.5.2 FINANCIAL OVERVIEW 123 11.5.3 SERVICES OFFERED 123 11.5.4 KEY DEVELOPMENTS 123 11.5.5 KEY STRATEGIES 123 11.6 BIO-TECHNE 125 11.6.1 COMPANY OVERVIEW 125 11.6.2 FINANCIAL OVERVIEW 126 11.6.3 SERVICES OFFERED 126 11.6.4 KEY DEVELOPMENTS 127 11.6.5 KEY STRATEGIES 127 11.7 ICON PLC 128 11.7.1 COMPANY OVERVIEW 128 11.7.2 FINANCIAL OVERVIEW 129 11.7.3 SERVICES OFFERED 129 11.7.4 KEY DEVELOPMENTS 129 11.7.5 SWOT ANALYSIS 130 11.7.6 KEY STRATEGIES 130 11.8 CHARLES RIVER LABORATORIES 131 11.8.1 COMPANY OVERVIEW 131 11.8.2 FINANCIAL OVERVIEW 132 11.8.3 SERVICES OFFERED 133 11.8.4 KEY DEVELOPMENTS 133 11.8.5 SWOT ANALYSIS 134 11.8.6 KEY STRATEGIES 134 11.9 SGS SOCIETE GENERALE DE SURVEILLANCE SA 135 11.9.1 COMPANY OVERVIEW 135 11.9.2 FINANCIAL OVERVIEW 135 11.9.3 PRODUCTS/SERVICES OFFERED 136 11.9.4 KEY DEVELOPMENTS 136 11.9.5 KEY STRATEGIES 136 11.10 BIOAGILYTIX LABS 137 11.10.1 COMPANY OVERVIEW 137 11.10.2 FINANCIAL OVERVIEW 137 11.10.3 SERVICES OFFERED 137 11.10.4 KEY DEVELOPMENTS 137 11.10.5 KEY STRATEGIES 137 11.11 SMITHERS 138 11.11.1 COMPANY OVERVIEW 138 11.11.2 FINANCIAL ANALYSIS 138 11.11.3 SERVICES OFFERED 138 11.11.4 KEY DEVELOPMENTS 138 11.11.5 KEY STRATEGIES 138 11.12 MESO SCALE DIAGNOSTICS, LLC 139 11.12.1 COMPANY OVERVIEW 139 11.12.2 FINANCIAL ANALYSIS 139 11.12.3 SERVICES OFFERED 139 11.12.4 KEY DEVELOPMENTS 139 11.12.5 KEY STRATEGIES 139 11.13 CMIC HOLDINGS CO., LTD 140 11.13.1 COMPANY OVERVIEW 140 11.13.2 FINANCIAL OVERVIEW 140 11.13.3 SERVICES OFFERED 141 11.13.4 KEY DEVELOPMENTS 141 11.13.5 KEY STRATEGIES 141 12 REFERENCES 142 12.1 RELATED REPORTS 143
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 20 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23 TABLE 3 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2032 (USD MILLION) 39 TABLE 4 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACOKINETIC (PK) STUDIES, BY REGION 2019–2032 (USD MILLION) 40 TABLE 5 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACODYNAMIC (PD) STUDIES, BY REGION 2019–2032 (USD MILLION) 41 TABLE 6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOEQUIVALENCE STUDIES, BY REGION 2019–2032 (USD MILLION) 41 TABLE 7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOMARKER TESTING, BY REGION 2019–2032 (USD MILLION) 42 TABLE 8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR IMMUNOGENICITY TESTING, BY REGION 2019–2032 (USD MILLION) 42 TABLE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019–2032 (USD MILLION) 43 TABLE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019–2032 (USD MILLION) 45 TABLE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ONCOLOGY, BY REGION 2019–2032 (USD MILLION) 46 TABLE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR INFECTIOUS DISEASES, BY REGION 2019–2032 (USD MILLION) 47 TABLE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION 2019–2032(USD MILLION) 47 TABLE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR NEUROLOGY, BY REGION 2019–2032(USD MILLION) 47 TABLE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR AUTOIMMUNE DISORDERS, BY REGION 2019–2032(USD MILLION) 48 TABLE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019–2032(USD MILLION) 48 TABLE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2019–2032(USD MILLION) 50 TABLE 18 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2019–2032 (USD MILLION) 51 TABLE 19 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION 2019–2032 (USD MILLION) 52 TABLE 20 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION 2019–2032 (USD MILLION) 52 TABLE 21 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION 2019–2032 (USD MILLION) 53 TABLE 22 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019–2032 (USD MILLION) 53 TABLE 23 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2019–2030 (USD MILLION) 55 TABLE 24 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 56 TABLE 25 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 56 TABLE 26 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 57 TABLE 27 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 59 TABLE 28 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 60 TABLE 29 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 60 TABLE 30 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 61 TABLE 31 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 61 TABLE 32 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 62 TABLE 33 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 62 TABLE 34 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 63 TABLE 35 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 63 TABLE 36 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 64 TABLE 37 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 67 TABLE 38 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 68 TABLE 39 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 68 TABLE 40 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 69 TABLE 41 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 69 TABLE 42 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 70 TABLE 43 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 70 TABLE 44 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 71 TABLE 45 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 71 TABLE 46 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 72 TABLE 47 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 72 TABLE 48 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 73 TABLE 49 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 73 TABLE 50 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 74 TABLE 51 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 74 TABLE 52 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 75 TABLE 53 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 75 TABLE 54 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 76 TABLE 55 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 76 TABLE 56 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 77 TABLE 57 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 77 TABLE 58 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 78 TABLE 59 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 78 TABLE 60 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 79 TABLE 61 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 79 TABLE 62 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 80 TABLE 63 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 80 TABLE 64 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 81 TABLE 65 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 81 TABLE 66 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 82 TABLE 67 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 82 TABLE 68 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 83 TABLE 69 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 83 TABLE 70 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 84 TABLE 71 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 84 TABLE 72 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 85 TABLE 73 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 85 TABLE 74 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 86 TABLE 75 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 86 TABLE 76 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 87 TABLE 77 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 87 TABLE 78 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 88 TABLE 79 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 88 TABLE 80 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 89 TABLE 81 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019–2030 (USD MILLION) 89 TABLE 82 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019–2030 (USD MILLION) 90 TABLE 83 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 93 TABLE 84 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 93 TABLE 85 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 94 TABLE 86 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 94 TABLE 87 CHINA 95 TABLE 88 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 95 TABLE 89 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 96 TABLE 90 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 96 TABLE 91 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 97 TABLE 92 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 97 TABLE 93 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 98 TABLE 94 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 98 TABLE 95 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 99 TABLE 96 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 99 TABLE 97 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 100 TABLE 98 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 100 TABLE 99 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 101 TABLE 100 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 101 TABLE 101 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 102 TABLE 102 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019–2030 (USD MILLION) 102 TABLE 103 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 103 TABLE 104 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 103 TABLE 105 MAJOR PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 105 TABLE 106 TOP 10 PHARMA COMPANIES FOR LARGE MOLECULE BIOANALYSIS 106 TABLE 107 TOP 10 CDMO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107 TABLE 108 TOP 10 CRO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107 TABLE 109 TOP 10 ACADEMIC AND RESEARCH INSTITUTIONS FOR LARGE MOLECULE BIOANALYSIS 108 TABLE 110 MOST ACTIVE PLAYER IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 109 TABLE 111 EXPANSION 110 TABLE 112 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 113 TABLE 113 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS 114 TABLE 114 PPD INC: SERVICES OFFERED 115 TABLE 115 PPD INC: KEY DEVELOPMENTS 115 TABLE 116 EUROFINS SCIENTIFIC: SERVICES OFFERED 118 TABLE 117 WUXI APPTEC: SERVICES OFFERED 122 TABLE 118 QPS HOLDINGS: SERVICES OFFERED 123 TABLE 119 QPS HOLDINGS: KEY DEVELOPMENTS 123 TABLE 120 BIOTECHNE: SERVICES OFFERED 126 TABLE 121 ICON PLC: SERVICES OFFERED 129 TABLE 122 CHARLES RIVER LABORATORIES: SERVICES OFFERED 133 TABLE 123 SGS SOCIETE GENRALE DE SURVEILLANCE SA: PRODUCTS/SERVICES OFFERED 136 TABLE 124 BIOAGILYTIX LABS: SERVICES OFFERED 137 TABLE 125 SMITHERS: SERVICES OFFERED 138 TABLE 126 MESO SCALE DIAGNOSTIC, LLC: SERVICES OFFERED 139 TABLE 127 CMIC HOLDINGS CO., LTD: SERVICES OFFERED 141   LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS 18 FIGURE 2 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 20 FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 26 FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 29 FIGURE 5 DRIVER IMPACT ANALYSIS 31 FIGURE 6 RESTRAINT IMPACT ANALYSIS 32 FIGURE 7 VALUE CHAIN ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 33 FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 35 FIGURE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, TEST TYPE, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 38 FIGURE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2022 & 2032 (USD MILLION) 39 FIGURE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY TEST TYPE, 2022 (%) 40 FIGURE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, THERAPEUTIC AREA, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 44 FIGURE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2022 & 2032 (USD MILLION) 45 FIGURE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY THERAPEUTIC AREA, 2022 (%) 46 FIGURE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 49 FIGURE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2022 & 2032 (USD MILLION) 50 FIGURE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY END USER, 2022 (%) 51 FIGURE 18 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022 & 2030 (USD MILLION) 54 FIGURE 19 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 55 FIGURE 20 NORTH AMERICA MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 58 FIGURE 21 NORTH AMERICA: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 59 FIGURE 22 NORTH AMERICA: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 59 FIGURE 23 EUROPE MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 65 FIGURE 24 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 66 FIGURE 25 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE (%), BY COUNTRY, 2022 67 FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 91 FIGURE 27 ASIA-PACIFIC: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 92 FIGURE 28 ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 92 FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS 106 FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 108 FIGURE 31 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET: COMPETITIVE LANDSCAPE 110 FIGURE 32 MAJOR PLAYERS SALES (USD MILLION), 2022 111 FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022 111 FIGURE 34 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 113 FIGURE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS 114 FIGURE 36 PPD INC: SWOT ANALYSIS 116 FIGURE 37 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 118 FIGURE 38 EUROFINS SCIENTIFIC: SWOT ANALYSIS 119 FIGURE 39 WUXI APPTEC: FINANCIAL OVERVIEW SNAPSHOT 121 FIGURE 40 BIOTECHNE: FINANCIAL OVERVIEW SNAPSHOT 126 FIGURE 41 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT 129 FIGURE 42 ICON PLC: SWOT ANALYSIS 130 FIGURE 43 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 132 FIGURE 44 CHARLES RIVER LABORATORIES: SWOT ANALYSIS 134 FIGURE 45 SGS SOCIETE GENRALE DE SURVEILLANCE SA: FINANCIAL OVERVIEW SNAPSHOT 135 FIGURE 46 CMIC HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 140  

提及公司

America Holdings (US)ICON plc (Ireland)SGS Société Générale de Surveillance SA (Switzerland)WuXi AppTec (China)Charles River Laboratories (US)Eurofins Scientific (luxembourg)QPS Holdings (US)BioTechne (US)PPDInc (US)BioAgilytix Labs (US)Smithers (US)Meso Scale DiagnosticLLC (US)and CMIC HOLDINGS CO.LTD (Japan)

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們